Optivar Ophthalmic Drops, Solution 0.05pct Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Optivar: Ophthalmic drops, solution (0.05%)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

AZELASTINE (a ZEL as teen) is an antihistamine. It is used in the eye to treat itching of eyes caused by hay fever or other allergies.

In-Depth Information
Select a Medication

Optivar 0.05% Ophthalmic Solution

NDC: 000377025
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Allergic Conjunctivitis, Ocular Pruritus

Storage Information
Store upright
Store between 36 to 77 degrees F
Optivar 0.05% Ophthalmic Solution

Reported Side Effects for Optivar 0.05% Ophthalmic Solution

Shortness Of Breath Incidence:
<10.0%*
Severity: MODERATE
Onset: EARLY
Headache Incidence:
<15.0%*
Severity: MILD
Onset: EARLY
Sore Throat Incidence:
<10.0%*
Severity: MILD
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Tired Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Eye Pain Incidence:
1.0-10.0%*
Severity: MILD
Onset: EARLY
Itching Incidence:
1.0-10.0%*
Severity: MILD
Onset: RAPID
Blurred Vision Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: EARLY
Conjunctivitis Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Rhinitis Incidence:
1.0-17.0%*
Severity: MILD
Onset: EARLY
Metallic Taste Incidence:
>2.0%*
Severity: MILD
Onset: EARLY
Eye Irritation Incidence:
30.0%*
Severity: MILD
Onset: RAPID
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Compatible - This drug is generally safe to take by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Optivar

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5